Injecto Polymers
Close ·
Key Fundamentals
SMEPrice-based figures at the close · TTM
- ROCE
- 19.00%
- Debt to Equity
- 2.62
- EPS (TTM)
- —
- Book Value
- ₹57.46
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 1.63
- ROE
- 28.90%
- Dividend Yield
- 0.00%
- EBITDA
- ₹38.30 Cr
- 52W High
- ₹100.25
- 52W Low
- ₹85.99
Key Insights
Strengths
3- Company has delivered good profit growth of 61.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%
- Company's working capital requirements have reduced from 32.5 days to 24.1 days
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 3 | 13 | 3 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Neutral | 2 | 6 | 2 |
Oscillators
Neutral
Overall
Neutral
Moving Averages
Neutral
Key readings
- RSI (14)
- 48.50
- Neutral
- MACD (12,26,9)
- —
- Neutral
- SMA (50)
- —
- Neutral
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +50.31% |
|---|---|
| 3Y | +57.63% |
| 1Y | +44.06% |
Net profit
| 5Y | +74.11% |
|---|---|
| 3Y | +100.00% |
| 1Y | +100.00% |
Operating cash flow
| 5Y | Turned negative |
|---|---|
| 3Y | Outflow widened by ₹47 Cr |
| 1Y | Outflow widened by ₹32 Cr |
Operating margin· change in pp
| 5Y | −0.09 pp |
|---|---|
| 3Y | +1.78 pp |
| 1Y | +1.30 pp |
Trailing twelve months: No quarterly results are reported.
Revenue by year
| Mar 2021 | ₹49.00 Cr |
|---|---|
| Mar 2022 | ₹88.00 Cr |
| Mar 2023 | ₹96.00 Cr |
| Mar 2024 | ₹109 Cr |
| Mar 2025 | ₹261 Cr |
| Mar 2026 | ₹376 Cr |
Net profit by year
| Mar 2021 | ₹1.00 Cr |
|---|---|
| Mar 2022 | ₹1.00 Cr |
| Mar 2023 | ₹2.00 Cr |
| Mar 2024 | ₹4.00 Cr |
| Mar 2025 | ₹8.00 Cr |
| Mar 2026 | ₹16.00 Cr |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 49 | 88 | 96 | 109 | 261 | 376 |
| Expenses | 44 | 81 | 88 | 97 | 239 | 338 |
| Operating Profit | 5 | 6 | 8 | 12 | 23 | 38 |
| OPM % | 9% | 7% | 8% | 11% | 9% | 10% |
| Other Income | 0 | 2 | 0 | 1 | 0 | 1 |
| Interest | 3 | 5 | 5 | 6 | 9 | 12 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 3 |
| PBT | 1 | 1 | 1 | 5 | 11 | 23 |
| Tax % | −75% | 15% | −56% | 10% | 28% | 32% |
| Net Profit | 1 | 1 | 2 | 4 | 8 | 16 |
| EPS (₹) | 1.58 | 1.26 | 1.77 | 3.32 | 5.34 | 10.55 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 12 | 13 | 15 | 15 |
| Reserves | 2 | 3 | 6 | 8 | 32 | 48 |
| Borrowings | 29 | 57 | 64 | 83 | 101 | 165 |
| Other Liabilities | 15 | 20 | 27 | 17 | 22 | 42 |
| Total Liabilities | 55 | 89 | 108 | 121 | 171 | 271 |
| Fixed Assets | 15 | 33 | 32 | 33 | 41 | 42 |
| CWIP | 13 | 0 | 2 | 2 | 2 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 27 | 56 | 74 | 86 | 128 | 228 |
| Total Assets | 55 | 89 | 108 | 121 | 171 | 271 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | 10 | −16 | −2 | −13 | −17 | −49 |
| Investing | −11 | −6 | −3 | −3 | −9 | −3 |
| Financing | 1 | 22 | 5 | 16 | 26 | 52 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | −1 | −22 | −5 | −16 | −26 | −52 |
| CFO/EBITDA | 228 | −258 | −29 | −103 | −71 | −124 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 122 | 117 | 115 | 105 | 50 | 62 |
| Inventory Days | 54 | 105 | 167 | 175 | 126 | 165 |
| Days Payable | 104 | 92 | 125 | 56 | 26 | 34 |
| Cash Conversion Cycle | 72 | 130 | 157 | 224 | 149 | 194 |
| Working Capital Days | 20 | 109 | 42 | 53 | 21 | 24 |
| ROCE % | — | 12% | 9% | 12% | 16% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Injecto Polymers insights
33 extracted metrics across FY21–FY26.
Documents
- 4 May 2026
- 17 Feb 2025
- 10 Apr 2024
- General announcements 28 Oct 2026
Frequently Asked Questions about Injecto Polymers
What does Injecto Polymers Ltd do?
Where is Injecto Polymers Ltd (INJECTO) listed?
Which sector does Injecto Polymers Ltd belong to?
What is the 52-week high and low of Injecto Polymers Ltd?
What is the Return on Equity (ROE) of Injecto Polymers Ltd?
Company Information
Incorporated in September 1998, Injecto Polymers Private Limited is engaged in the manufacturing of a diverse range of plastic packaging products and trading of plastic granules and Polyvinyl Chloride (PVC) resins.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544930.md for Injecto Polymers Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.